Maltzman Julia D. 4
4 · Adicet Bio, Inc. · Filed Feb 4, 2025
Insider Transaction Report
Form 4
Adicet Bio, Inc.ACET
Maltzman Julia D.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-31+750,000→ 750,000 totalExercise: $0.89Exp: 2035-01-30→ Common Stock (750,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the stock option shall vest on December 7, 2025, and the remainder of the shares shall vest in equal monthly installments for a period of 36 months thereafter, provided that the Reporting Person maintains a service relationship with the Issuer as of the applicable vesting dates.